HOOKIPA Pharma Inc logo

HOOK - HOOKIPA Pharma Inc Share Price

$8.34 0.4  5.4%

Last Trade - 7:50pm

Sector
Healthcare
Size
Small Cap
Market Cap £187.0m
Enterprise Value £100.4m
Revenue £9.59m
Position in Universe 3286th / 6323
Bullish
Bearish
Unlock HOOK Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

HOOK Revenue Unlock HOOK Revenue

Net Income

HOOK Net Income Unlock HOOK Revenue

Normalised EPS

HOOK Normalised EPS Unlock HOOK Revenue

PE Ratio Range

HOOK PE Ratio Range Unlock HOOK Revenue

Dividend Yield Range

HOOK Dividend Yield Range Unlock HOOK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
HOOK EPS Forecasts Unlock HOOK Revenue
Profile Summary

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is developing products to prevent and cure infectious diseases and cancer. The Company's infectious and oncology product candidates HB-101, HB-201 and HB-202. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company offers VaxWave technology, which is designed to induce a robust CD8+ T cell and pathogen neutralizing response to fight disease. VaxWave technology supports the benefits of our arenavirus platform approach.

Directors
Last Annual December 31st, 2019
Last Interim December 31st, 2019
Incorporated February 15, 2017
Public Since April 18, 2019
No. of Shareholders: n/a
No. of Employees: 85
Sector Healthcare
Industry Pharmaceuticals
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 29,464,454
Free Float (0.0%)
Eligible for
ISAs
SIPPs
HOOK Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for HOOK
Upcoming Events for HOOK
Similar to HOOK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.